EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Global Burden of Bloodstream Infections in COVID-19: Prevalence, Antimicrobial Resistance, and Mortality Risk

Diana-Maria Mateescu iD, Adrian-Cosmin Ilie, Ioana Cotet, Cristina Guse, Camelia-Oana Muresan iD, Ana-Maria Pah, Marius Badalica-Petrescu, Stela Iurciuc, Maria-Laura Craciun, Adina Avram iD, Alexandra Enache

Viruses · 09.10.2025 · 17 (10) · 1353

DOI: 10.3390/v17101353 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Viruses, online erschienen am 09.10.2025. Verfasst von Diana-Maria Mateescu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Department of General Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romani…. Hauptthemen laut MEDLINE: COVID-19, Bacteremia, Sepsis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy Timisoara, Romania, “Victor Babes” University of Medicine and Pharmacy Timisoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bloodstream infections (BSIs) complicate COVID-19 inpatients, increasing morbidity, mortality, and healthcare burden. This systematic review and meta-analysis evaluated prevalence, antimicrobial resistance (AMR), risk factors, and outcomes of BSIs in RT-PCR-confirmed COVID-19 cases.

Methods

We searched PubMed, Google Scholar, ScienceDirect, and MDPI journals (January 2020–August 2025) following PRISMA 2020 guidelines. Twenty-two observational studies (~123,500 patients, ~602,000 blood cultures) were included: 10 prospective and 12 retrospective. Random-effects models estimated pooled prevalence, odds ratios (ORs), and mean differences, with subgroup analyses (ICU, non-ICU, pediatric) and meta-regression.

Results

Pooled BSI prevalence was 8.2% (95% CI: 5.7–11.0; I2 = 50%). Subgroup prevalence was higher in ICU (12.5%) than non-ICU (5.2%) populations. Pediatric cohorts (n = 3) showed a prevalence of 10.8%. Gram-negative pathogens predominated (61%), particularly Klebsiella pneumoniae (26%) and Acinetobacter baumannii (21%). AMR rates were 36% for MRSA and 31% for ESBL-producing Enterobacterales. Risk factors included mechanical ventilation (OR: 2.6), immunosuppression (OR: 2.3), and corticosteroid use (OR: 2.4). BSIs were associated with increased mortality (OR: 2.6), prolonged hospitalization (+6.8 days), and higher ICU admission (OR: 3.1).

Conclusions

BSIs, largely driven by multidrug-resistant pathogens, substantially worsen COVID-19 outcomes. Variability in diagnostic criteria (CDC vs. ECDC) and reliance on retrospective designs are limitations, though moderate heterogeneity (I2 = 50%) enhances generalizability across diverse populations. Strengthened infection prevention and antimicrobial stewardship are urgently required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19BacteremiaSepsisHumansPrevalenceRisk FactorsSARS-CoV-2Drug Resistance, BacterialAnti-Bacterial Agents

Stichwörter der Autor:innen

COVID-19ICUantimicrobial resistancebloodstream infectionsmeta-analysismortalitypediatric

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Doctoral School, Department of General Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Department of Public Health and Sanitary Management, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Legal Medicine, Timisoara Institute of Legal Medicine, 300041 Timisoara, Romania.
  • Ethics and Human Identification Research Center, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Discipline of Forensic Medicine, Bioethics, Deontology, and Medical Law, Department of Neuroscience, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

ORCID-Profile: Diana-Maria Mateescu, Camelia-Oana Muresan, Adina Avram

Förderung

  • Victor Babes University of Medicine and Pharmacy Timisoara, Romania
  • “Victor Babes” University of Medicine and Pharmacy Timisoara

Zitieren

APA

Mateescu, D. M., Ilie, A. C., Cotet, I., Guse, C., Muresan, C. O., Pah, A. M., Badalica-Petrescu, M., Iurciuc, S., Craciun, M. L., Avram, A., & Enache, A. (2025). Global Burden of Bloodstream Infections in COVID-19: Prevalence, Antimicrobial Resistance, and Mortality Risk. Viruses, 17(10), 1353. https://doi.org/10.3390/v17101353

Vancouver

Mateescu DM, Ilie AC, Cotet I, Guse C, Muresan CO, Pah AM, et al. Global Burden of Bloodstream Infections in COVID-19: Prevalence, Antimicrobial Resistance, and Mortality Risk. Viruses. 2025;17(10):1353. doi:10.3390/v17101353

BibTeX
@article{Mateescu2025,
  author = {Mateescu, Diana-Maria and Ilie, Adrian-Cosmin and Cotet, Ioana and Guse, Cristina and Muresan, Camelia-Oana and Pah, Ana-Maria and Badalica-Petrescu, Marius and Iurciuc, Stela and Craciun, Maria-Laura and Avram, Adina and Enache, Alexandra},
  title = {Global Burden of Bloodstream Infections in COVID-19: Prevalence, Antimicrobial Resistance, and Mortality Risk},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1353},
  doi = {10.3390/v17101353}
}
Kostenlos starten →